Ibha Sedenu
Psychiatric/Mental Health · Maitland, FLNPI 1467701177
Payments from drug & device makers
Across 385 payments — averaging $23.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Alkermes, Inc.$1K
- Tris Pharma Inc$818
- Axsome Therapeutics, Inc.$770
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$719
- Otsuka America Pharmaceutical, Inc.$588
- plus $3K from 20 others
What the payments were for
- Food & beverage$8,93399%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $1,818 |
| Alkermes, Inc. | 40 | $1,051 |
| Tris Pharma Inc | 32 | $818 |
| Axsome Therapeutics, Inc. | 20 | $770 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 37 | $719 |
| Otsuka America Pharmaceutical, Inc. | 34 | $588 |
| Teva Pharmaceuticals USA, Inc. | 19 | $467 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $400 |
| Neurocrine Biosciences, Inc. | 18 | $379 |
| Vanda Pharmaceuticals Inc. | 16 | $321 |
| Lundbeck LLC | 13 | $309 |
| Supernus Pharmaceuticals, Inc. | 8 | $257 |
| Bausch Health US, LLC | 8 | $202 |
| Almatica Pharma LLC | 10 | $200 |
| Johnson & Johnson | 8 | $170 |
| Corium, LLC | 6 | $124 |
| Livanova USA, Inc. | 1 | $120 |
| Sunovion Pharmaceuticals Inc. | 6 | $104 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Indivior Inc. | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Merck | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$481
- Auvelity$354
- VRAYLAR$347
- Austedo XR$226
- QELBREE$126
- VNS Therapy Symmetry Model 8103 Generator$120
- Dyanavel XR$120
- QULIPTA$117
- UBRELVY$117
How this compares
$8,980 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxyzine Pamoate | 11 | $261 |
| Clonazepam | 16 | $204 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 25 | $177 |
| Temazepam | 13 | $147 |
| Escitalopram Oxalate | 14 | $80 |
| Alprazolam | 15 | $25 |
| Quetiapine Fumarate | 16 | $18 |
| Buspirone Hcl | 13 | $6 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Maitland
- Hannah PhillipsMaitland$455K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.